eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | crohn disease |
| Comorbidity | C0002726|amyloidosis |
| Sentences | 7 |
| PubMedID- 21175229 | Secondary amyloidosis in a patient with long duration crohn's disease treated with infliximab. |
| PubMedID- 25969738 | One previous study reported that 15 (0.9%) of 1709 patients with crohn's disease were complicated by secondary amyloidosis and only three patients had amyloid deposition in the thyroid (8). |
| PubMedID- 24078992 | Effect of infliximab induction therapy on secondary systemic amyloidosis associated with crohn's disease: case report and review of the literature. |
| PubMedID- 21603298 | Secondary amyloidosis is a result of chronic inflammatory disease (crohn's disease, adult or juvenile rheumatoid arthritis, reiter's syndrome, ankylosing spondylitis, familial mediterranean fever, sjögren's syndrome, dermatomyositis, vasculitis, chronic osteomyelitis, tuberculosis, bronchiectasis, cystic fibrosis, systemic lupus erythematosus, and so on) and has a median survival of 4.5 years (10, 11). |
| PubMedID- 22359896 | [secondary (aa) amyloidosis in crohn's disease]. |
| PubMedID- 21453891 | Infiximab for treatment of systemic amyloidosis associated with crohn's disease. |
| PubMedID- 21509909 | Efficacy of scheduled infliximab maintenance therapy on systemic amyloidosis associated with crohn's disease. |
Page: 1